A Phase 1 Study of Ipilimumab in Combination with Decitabine in Relapsed or Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia

IRB/UVA Tracking #
20233
Contact
Megan Healy
Contact Phone
Phase
I
Primary purpose
Treatment
Cancer PI
Michael Keng
Status
OPEN TO ACCRUAL
Ages
Adult